Valuation: DBV Technologies

Market Cap 671M 744M 619M 560M 1.06B 69.77B 1.09B 7.42B 2.96B 37.37B 2.79B 2.73B 119B P/E 2026 *
-5.21x
P/E 2027 * -14.8x
Enterprise Value 603M 669M 557M 504M 953M 62.79B 977M 6.68B 2.66B 33.63B 2.51B 2.46B 107B EV / Sales 2026 *
181x
EV / Sales 2027 * 8.61x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
1 day+6.38%
1 week+20.98%
Current month+25.53%
1 month+27.18%
3 months-12.68%
6 months-38.78%
Current year-36.86%
1 week 1.67
Extreme 1.673
2.18
1 month 1.53
Extreme 1.534
2.18
Current year 1.53
Extreme 1.534
4.4
1 year 1.53
Extreme 1.534
4.5
3 years 0.51
Extreme 0.506
4.5
5 years 0.51
Extreme 0.506
5.68
10 years 0.51
Extreme 0.506
86.64
Manager TitleAgeSince
Chief Executive Officer 66 29/11/2018
Director of Finance/CFO 56 06/11/2023
Chief Operating Officer - 01/12/2023
Director TitleAgeSince
Director/Board Member 51 21/10/2015
Director/Board Member 63 21/06/2016
Director/Board Member 60 15/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
7/29/26 A Sell

Chief Technology Officer

-464 0.0002%
1/29/26 A Sell

Chief Technology Officer

534 0.0003%
1/12/26 A
Baker Bros. Advisors LP
ExerciceCompany 54,609,792 27.1991%
Change 5-day change 1-year change 3-year change Capi.($)
+6.38%+20.98%-12.18%+14.00% 703M
+0.35%+1.36%+45.38%+140.47% 1,276B
-0.13%+1.48%+44.67%+90.43% 676B
+0.37%+0.05%+31.00%+112.84% 519B
+0.02%+1.52%+39.21%+69.76% 388B
-0.59%-2.11%+61.83%+45.16% 365B
-1.29%-1.13%+27.54%+58.29% 307B
+0.09%-0.91%+3.19%+37.72% 287B
+0.62%-2.17%+38.31%+75.12% 252B
-0.67%-2.72%+38.49%+123.56% 212B
Average +0.67%+2.10%+31.74%+76.73% 428B
Weighted average by Cap. +0.47%+0.56%+39.49%+97.21%

Financials

2026 *2027 *
Net sales 3.35M 3.72M 3.1M 2.8M 5.3M 349M 5.43M 37.11M 14.79M 187M 13.96M 13.66M 594M 64.94M 72.05M 60M 54.24M 103M 6.76B 105M 719M 287M 3.62B 270M 265M 11.52B
Net income -200M -222M -185M -167M -316M -20.8B -324M -2.21B -882M -11.14B -832M -815M -35.46B -143M -159M -133M -120M -227M -14.92B -232M -1.59B -633M -7.99B -597M -585M -25.44B
Net Debt -67.1M -74.45M -61.99M -56.04M -106M -6.98B -109M -743M -296M -3.74B -279M -273M -11.9B -119M -132M -110M -99.43M -188M -12.39B -193M -1.32B -525M -6.64B -496M -485M -21.11B
Projected Income Statement - Annual - DBV Technologies
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
179
Date Price Change Volume
11/11/26 €2.134 +6.38% 1,681,461
10/11/26 €2.006 +2.35% 1,152,610
09/11/26 €1.960 +9.19% 1,299,263
06/11/26 €1.795 +3.58% 884,248
05/11/26 €1.733 -1.76% 1,197,562
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - DBV Technologies
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
2.134EUR
Average target price
3.633EUR
Spread / Average Target
+70.26%